Ocugen, Inc. (OCGN) stock
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.74−0.02 (-2.31%)
Close on Nov 18, 2026Market cap $250.67MP/E –Yield –
Ocugen revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Ocugen's revenue for the twelve months ending Sep 30, 2025 was $5.37M, up 14.3% year over year. For fiscal 2025 it was $4.41M, up 8.8% from the year before. The highest annual figure on record is $6.04M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.41M | +8.8% |
| FY2024 | Dec 31, 2024 | $4.06M | -32.8% |
| FY2023 | Dec 31, 2023 | $6.04M | +142.6% |
| FY2022 | Dec 31, 2022 | $2.49M | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $43.00K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | – |
| FY2014 | Dec 31, 2014 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.49M | +0.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.53M | +100.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.75M | +54.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.37M | +20.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.48M | +46.1% |
| Q4 FY2024 | Dec 31, 2024 | $764.00K | -45.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.14M | -69.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.14M | +135.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.01M | +128.9% |
| Q4 FY2023 | Dec 31, 2023 | $1.41M | +60.3% |
| Q3 FY2023 | Sep 30, 2023 | $3.70M | +693.8% |
| Q2 FY2023 | Jun 30, 2023 | $485.00K | -24.6% |
| Q1 FY2023 | Mar 31, 2023 | $443.00K | -11.4% |
| Q4 FY2022 | Dec 31, 2022 | $879.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $466.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $643.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $500.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $43.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?